Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.
Ravandi
Farhad
F
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. fravandi@mdanderson.org
Cortes
Jorge
J
Faderl
Stefan
S
O'Brien
Susan
S
Garcia-Manero
Guillermo
G
Verstovsek
Srdan
S
Santos
Fabio P S
FP
Shan
Jianqin
J
Brandt
Mark
M
de Lima
Marcos
M
Pierce
Sherry
S
Kantarjian
Hagop
H